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Abstract
Flow cytometry is a widely used technique for the analysis of cell populations in the study and diagnosis of human diseases.
It yields large amounts of high-dimensional data, the analysis of which would clearly benefit from efficient computational
approaches aiming at automated diagnosis and decision support. This article presents our analysis of flow cytometry data in
the framework of the DREAM6/FlowCAP2 Molecular Classification of Acute Myeloid Leukemia (AML) Challenge, 2011. In the
challenge, example data was provided for a set of 179 subjects, comprising healthy donors and 23 cases of AML. The
participants were asked to provide predictions with respect to the condition of 180 patients in a test set. We extracted
feature vectors from the data in terms of single marker statistics, including characteristic moments, median and interquartile
range of the observed values. Subsequently, we applied Generalized Matrix Relevance Learning Vector Quantization
(GMLVQ), a machine learning technique which extends standard LVQ by an adaptive distance measure. Our method
achieved the best possible performance with respect to the diagnoses of test set patients. The extraction of features from
the flow cytometry data is outlined in detail, the machine learning approach is discussed and classification results are
presented. In addition, we illustrate how GMLVQ can provide deeper insight into the problem by allowing to infer the
relevance of specific markers and features for the diagnosis.
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Introduction
We present in this article our main results obtained in the
context of the DREAM6/FlowCAP2 Molecular Classification of Acute
Myeloid Leukemia Challenge 2011 [1–3]. This challenge was
organized in a joint effort by the Dialogue for Reverse Engineering
Assessments and Methods (DREAM) project [3–6] and the Flow
Cytometry: Critical Assessment of Population Identification Methods (Flow-
CAP) initiative [2].
Flow cytometry constitutes a powerful technique which is widely
used in medical research and clinical practice for the study and
diagnosis of various diseases [7]. Flow cytometry measurements
typically yield a quantitative description of several tens or even
hundreds of thousands of cells in a given sample. Light scatter and
fluorescence properties are used to identify deviations from normal
cell size or structure and to quantify functional properties in terms
of, e.g., protein marker expressions [7,8]. The amount of available
data, its high dimension, and the complexity of the diagnosis tasks
trigger a significant interest in systems for automated analysis and
decision support.
Along these lines, the DREAM6/FlowCAP2 challenge ad-
dressed the analysis of given flow cytometry data, representing
peripheral blood and bone marrow samples of, in total, 359
subjects. Some of these corresponded to cases of Acute Myeloid
Leukemia (AML) and the ultimate goal was to predict the
condition of a number of patients whose diagnosis was unknown to
the participants. Hence, the goal of the challenge could be
formulated as a machine learning problem: From the given
example data with known diagnoses, criteria were to be inferred
which then allowed for the classification of the test samples.
We extracted feature vectors from the data in terms of a few
characteristic quantities, summarizing the statistics of the observed
marker values. Predictions were obtained by means of a specific
machine learning technique termed Generalized Matrix Rele-
vance Learning Vector Quantization (GMLVQ) [9–11]. This
prototype based method extends standard Learning Vector
Quantization [12,13] by using Adaptive Distance Measures in Relevance
LVQ, which motivated the acronym and team name Admire-LVQ.
In the challenge, our team achieved the best possible performance
with respect to the required test set prediction.
In the following section a description of the data set and our
analysis is given. Thereafter we present and discuss our main
results and the obtained prediction. We conclude with a brief
outlook on possible extensions and future work.
Data Set and Analysis
In this section we first describe the extraction of features from
the given data. The specific machine learning analysis based on
Generalized Matrix Relevance Learning Vector Quantization is
outlined. Furthermore, its validation in terms of the given data set
is discussed.
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The data set provided in the challenge comprised 359 subjects.
For each of these, a varying number of cells, on the order of a few
thousands, had been analysed by means of flow cytometry, see
[2,3] for details. The first 179 subjects served as the training data;
label information Sm [ f1,2g, m~1,2, . . . ,179 was provided,
specifying 23 subjects as AML patients (Sm~2). The remaining
156 subjects are referred to as healthy donors (Sm~1) throughout
this contribution. Note that the latter group of subjects includes
a number of patients with a diagnose different from AML [14].
The task was to predict the diagnosis with respect to a test set of
180 subjects for which no label information was provided. The
total number of AML cases in the test set, 20, was also disclosed to
the participants. However, this information was not exploited in
our approach. We have analysed the transformed and compensated
flow cytometry data as provided by the organizers of the challenge
[2,3]. In our analysis we omitted the non-specific isotope control
data representing non-human binding antibodies, which corre-
sponds to tube 8 in the data set [3].
In clinical practice, a possible workflow is to sort cells according
to a small number of gating variables in a first step, identifying
potentially degenerate or immature cells. Subsequently, the
selected cells are analysed according to the remaining markers,
aiming at a reliable diagnosis and potential identification of the
AML subtype [7,8]. In our approach we follow a simpler, more
direct strategy in which we omit cell specific information. After
visual inspection in terms of histograms we decided to represent
the data by a limited number of statistical characteristics per
patient and marker. Moreover, we took into account all markers at
once in order to assign each subject to one of the two classes in
a single processing step.
Feature Extraction and Normalization
A key step in the design of a classifier in this challenge was the
extraction of appropriate features from the provided data. The
data corresponding to tubes 1–7 represents 31 characteristic
quantities per cell: the so-called Forward Scatter on linear scale
(FS Lin), the Sideward Scatter on logarithmic scale (SS Log), and 29
fluorescence intensities on logarithmic scale quantifying the
expression of various surface proteins. All of these quantities are
referred to as markers in the following. Table 1 lists the considered
markers and the index j~1,2 . . . 31 which we refer to in the
analysis.
Note that the potential gating markers FS Lin, SS Log, and
CD45-EDC were provided for all cells in the data set. The other
28 markers were measured in one tube only, representing a sub-
population of cells per subject. We rescaled all markers by the
respective largest possible value as to limit all observations to the
interval ½0,1.
FS Lin can be interpreted as a measure of cell size, while SS Log
roughly quantifies intracellular granularity [7]. Note furthermore
that the expression of IgG1 was measured by means of four
different binding antigens. In our analysis, however, the
corresponding values were treated as four independent markers
(j~4,11,18,25), formally.
For the purpose of a first, visual inspection, we computed
histograms corresponding to the frequency of marker values in the
training set. Figures 1 and 2 display histograms of 4 example
markers: FS Lin (j~1), SS Log (j~2), CD45-EDC (j~3), and
CD10-PC7 (j~31) for one patient per class (m~100 and103). The
main purpose of Figures 1 and 2 is to illustrate the extraction of
feature vectors from the sample data which is described in the
following.
For each patient and marker a varying number M of cell
measurements, typically a few thousands, were made available. In
our analysis, we did not make use of cell specific information, as it
is done frequently in terms of a so-called gating procedure in
clinical practice [7,8]. We extracted information only on the level
of single marker statistics over the entire population of cells. A
direct classification of histograms using, for instance, entropic
distance measures or statistical divergences would be feasible here
[15,16]. We resorted, however, to reducing the information to
only six quantities per marker which summarize the characteristics
of the corresponding histogram. We denote by v
m
j (m) the value
measured for marker j (1ƒjƒ31) in individual cell
m (1ƒmƒMm) of patient m. From the available data we










































Table 1. List of the 31 markers used in the analysis.
1 2 3 4 5 6 7 8
FS Lin SS Log CD45- EDC IgG1- FITC Kappa- FIT CD7- FITC CD15- FITC CD14- FITC
9 10 11 12 13 14 15 16
HLADR- FITC CD5- FITC IgG1- PE Lambda- PE CD4- PE CD13- PE CD11c- PE CD117- PE
17 18 19 20 21 22 23 24
CD19- PE IgG1- PC5 CD19- PC5 CD8- PC5 CD16- PC5 CD64- PC5 CD34- PC5 CD3- PC5
25 26 27 28 29 30 31
IgG1- PC7 CD20- PC7 CD2- PC7 CD56- PC7 CD33- PC7 CD38- PC7 CD10- PC7
doi:10.1371/journal.pone.0059401.t001
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In addition we computed (e) median (med
m
j ) and (f) interquartile
range (iqr
m





is a measure of the asymmetry, with positive values indicating that
more weight is contained in the left side of the histogram. The kurtosis
quantifies how sharply peaked a histogram is. Note that in the
above defined kurt, sometimes termed excess kurtosis in the
literature, a constant 3 is subtracted yielding kurt~0 in case of
normal densities.
Hence we obtained, for each patient m, a set of 6 quantities per
marker. A particular subject was subsequently represented by the
concatenated vector xm [ RN of N~186 characteristic features.
As one example, the skewness of marker 17 (CD19-PE, see
Table 1) observed for patient 42 corresponds to component
skew4217~x
42
99 of the feature vector x
42 since (17{1):6z3~99.
The features representing markers 1–3 (FS Lin, SS Log, CD45-
EDC) and marker 31 (CD10-PC7) are shown for one example
subject from each class in Figures 1 and 2, together with the
corresponding histograms.
In the training processes described in the following, we applied
an additional z-score transformation: Given a (sub-)set of P

















and rescaled all features in training, validation or test data by
subtracting the mean xi and subsequently dividing by si.
Consequently, the transformed features display zero mean and
unit variance in the actual training set. While the transformation
did not affect the classification performance, it enhances the
interpretability of the results, in particular with respect to the
relevance matrix, see below.
Matrix Relevance Learning Vector Quantization
We employed Generalized Matrix Relevance Learning Vector
Quantization (GMLVQ) for the analysis of the obtained feature
vectors. This highly flexible and powerful variant of LVQ is
described in detail in [9–11]. Here we employed the algorithm in
its simplest setting with one prototype per class and a single, global
relevance matrix as defined below.
The two classes, i.e. healthy donors (class 1) and AML patients
(class 2), are represented by the prototype vectors w1,w2 [ RN ,
respectively. Given a particular z-score-transformed feature vector
x [ RN representing one of the patients, its distance from the
prototypes is determined as
Figure 1. Example histograms and extracted features: FS Lin and SS Log. Histograms and extracted features correspond to one healthy
donor (subject m~100, upper panels) and one AML patient (subject m~103, lower panels), respectively. Histograms display the frequency of
a particular marker value for visual inspection. Six features are extracted per patient and marker, corresponding to mean, standard deviation,
skewness, kurtosis, median, and interquartile range of the observed frequency of marker values, cf. Eq. (1). Here the first 12 components of the 186-
dim. feature vectors are displayed before z-score transformation.
doi:10.1371/journal.pone.0059401.g001
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Here L and V are N|N matrices and the specific parame-




In a simple Nearest Prototype Classification (NPC) scheme, a feature
vector x is assigned to class 1 if d(x,w1)vd(x,w2) and to class 2,
else. While w1,2 serve as typical representatives of the classes,
elements Lij of the symmetric matrix L can be interpreted as to
quantify the relevance of a pair of feature dimensions i,j in the
classification scheme.
Both, prototypes and relevances, are determined in the same
supervised training process. Given a set of P examples xm,Smf gPm~1
with class labels Sm [ 1,2f g, training is guided by the minimization









where the index J corresponds to the correct prototype with J~Sm
while K=Sm identifies the wrong prototype. In general, the
objective of training can be further specified by introducing
a function W(em) in the cost function, e.g. a sigmoidal [17]. Here, we
resorted to the simple case W(x)~x. Note that the contribution em
of a single example to the cost function satisfies {1vemv1. It is
negative if xm is classified correctly and its absolute value relates to
the margin of the classification.










A value s(x)&0 indicates that feature vector x is assigned to
class 1, healthy donors, with high certainty. Large values close to
s~1 signal confident classification as an AML patient (class 2).
The NPC scheme can be reformulated as assigning vector x to
class 1 if s(x)ƒ1=2 and to class 2 else. While the score may serve
as a relative measure of certainty in GMLVQ, it should not be
Figure 2. Example histograms and extracted features: CD45-EDC and CD10-PC7. For further description see Figure 1. The quantities
displayed here correspond to features 13–18 and 181–186 of the 186-dim. vectors before z-score transformation.
doi:10.1371/journal.pone.0059401.g002
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interpreted directly as a probability for AML. Note that any
monotonically increasing function f : ½0,1?½0,1 could be used to
transform s without modifying the actual ordering of patients
according to s.
We implemented the iterative optimization of E, cf. Eq. (4), by
means of a gradient descent procedure with respect to the adaptive
quantities w1,w2, and V. At iteration step t, updates along the














eV(tz1)~V(t){aV(t) LELV =DLELVD ð6Þ
with the time-dependent step sizes aw(t) and aV(t). The full form
of the gradient terms is given in [9,11,19], for instance. We
employed gradient descent with waypoint averaging and step size control,
which has been introduced and described in greater detail in [19]:
After a gradient step, Eq. (6), the achieved value of the cost















corresponds to the position in search space, on average over the
last T updates. The observation of E
^
(tz1)vE(tz1) signals
oscillatory behavior of the iteration. In this case, we set
wi(tz1)~wi(t) and V(tz1)~V(t) and reduced the step sizes
by a factor av1 : aw,V(tz1)~a:aw,V(t). All results presented
here were obtained with parameters T~3 and a~2=3 in the
waypoint averaging scheme. Initial step sizes were aw(0)~10=N
for prototypes and aV(0)~100=N for matrix updates, respectively.
In the problem at hand, the obtained classification scheme and
error rates turned out very robust with respect to the choice of
these parameters.
For a given training set, we initialized prototypes w1,2 close to
the corresponding class conditional means with small random












where the Kronecker–Delta dmn~1 if m~n and dmn~0 if m=n.
The components of r [ RN and all elements of C [ RN|N were
generated independently according to a uniform density
U({0:1,0:1). Results were found to depend only very weakly
on details of the initialization.
Validation
In order to evaluate the performance of the GMLVQ classifier
before applying it to the test set, we employed a validation scheme
based on randomized subsets of the available training data. In
every run we selected ca. 3=4 of the data from each class
randomly, i.e. 17 of the 23 AML examples and 117 of the 156
healthy donors. These P~134 example data were used for
training the GMLVQ system while the remaining 45 served as
a validation set. The random split of the data was repeated 50
times and, if not stated otherwise, results presented in this section
were obtained on average over the validation runs.
Figure 3 displays the averaged error rates of naı¨ve Nearest
Prototype Classification in the course of gradient based training.
Note that an over-fitting effect was observed: Performing more
than ca. 60 training steps decreased the error rates with respect to
training examples to very low values. At the same time, however,
validation set performance deteriorated. Closer inspection re-
vealed that this effect was essentially due to patient m~116, listed
as a case of AML in the training set. If contained in the validation
set, this patient was consistently misclassified by the NPC scheme.
On the contrary - if employed for training - the system achieved
agreement with the label, eventually, but at the expense of an
increased error rate in the validation set.
Based on this observation, we employed an early stopping strategy,
terminating the training process after 40 gradient steps. When
omitting patient m~116 from the training set or re-labeling the
subject as healthy donor, the learning curves converged smoothly
and overfitting was not observed anymore. Moreover, we obtained
virtually the same classification, i.e. the same order of scores with
respect to the test set patients in all these scenarios. The precise
numerical results reported in the following section were obtained
by means of the early stopping strategy including subject m~116
labelled as an AML case (S116~2).
In addition to the error rates of the naı¨ve NPC scheme we also
evaluated the validation set performance in terms of the Receiver
Operating Characteristics (ROC) [20]. By introducing a threshold
H, the GMLVQ scheme can be biased with respect to one of the
two classes:





with the score s defined in Eq. (5) For thresholds in the range
{1=2ƒHƒ1=2 we computed the corresponding class-wise error
rates with respect to the validation set on average over the 50
training runs, yielding the threshold-averaged ROC curves [20]
displayed in Figure 4.
The ROC analysis revealed very high sensitivity (true positive
rate) and specificity (1 - false positive rate) with respect to the
validation set performance, the corresponding Area Under Curve
being AUC~0:9935 [20]. In addition, removal of patient m~116
from the data set resulted in an almost perfect ROC with
AUC~0:9996. Given the close to error–free classification we
refrained from employing complementary performance measures
such as precision/recall or other characteristics [20]. For the same
reason, we did not compare the validation performance of the
simple GMLVQ scheme with more sophisticated settings or
alternative classifiers.
Results and Discussion
Final results, including the test set scores, were obtained using
all 179 training samples for training. In addition, we performed an
average over 50 randomized intializations in order to rule out an
Analysis of Flow Cytometry Data by Relevance LVQ
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influence of the initial configuration of the GMLVQ system. In
each run, 40 gradient steps were performed with waypoint
averaging and step size control as described above. The final test
set scores were obtained on average over the 50 randomized
training runs.
Before discussing the outcome of the GMLVQ training in terms
of prototypes and relevances we present the actual test set
predictions.
Test Set Prediction
Figure 5 displays the GMLVQ based scores s, cf. Eq. 5, with
respect to the 180 test set patients. Values close to s~1 correspond
to patients that are identified as AML patients with high certainty,
while small s&0 correspond to a classification as healthy donor. It
would be very interesting to study potential correlations of the
scores s with additional information about the patients, e.g.
measures of the severity of the AML cases. Unfortunately such
information was not disclosed and is not available for the given
data set.
Although it was known to the participants that the test set
contained 20 AML cases, we did not make explicit use of this
information. In the GMLVQ training, a threshold value does not
have to be specified. The result in terms of scores s and the
corresponding ranking of test set patients is independent of the
actual number of AML cases. In a practical context, and if a crisp
classification is the goal, the actual value of H should be set
according to domain expert (user) preferences concerning the
compromise between sensitivity and specificity. The example
threshold value marked in the right panel of Figure 5 was chosen
a posteriori for illustration purposes only and is neither a result nor
a parameter of the training process. With respect to performance
in the challenge it is irrelevant.
The comparison with the unknown test set labels after
submission of the predictions [3] revealed that the 20 patients
with highest GMLVQ score s corresponded precisely to the 20
Figure 3. Learning curves in the validation procedure. Class specific and total error rates of Nearest Prototype Classification, corresponding to
H~0 in Eq. (8), on average over 50 randomized validation runs. The upper panel corresponds to the performance in the respective training set, the
lower panel displays error rates with respect to the validation set. The curves correspond to including patient m~116 in training or validation set.
doi:10.1371/journal.pone.0059401.g003
Figure 4. Validation set performance. Threshold-averaged ROC as
obtained in the validation runs using labeled data. The curves
correspond to using the data set including patient m~116 (lower, blue
line) and excluding patient m~116 from the analysis completely (upper,
red line), respectively.
doi:10.1371/journal.pone.0059401.g004
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AML patients in the test set. Hence, we achieved the best possible
prediction according to Receiver Operator Characteristics or
other evaluation methods like Precision/Recall, which only
depend on the order of scores and the corresponding ranking of
patients.
The obtained classifier can be illustrated in terms of a two-
dimensional visualization: Figure 6 displays the training and test
data in terms of projections on the leading eigenvectors of the
relevance matrix L [21]. Two rather well separated clusters can be
identified which reflect the assignment of classes. Note that the
training set subject (patient 116) that was consistently misclassified
by the NPC scheme is, indeed, located in the cluster representing
healthy donors. This relates to the overfitting behavior discussed in
greater detail in the previous section.
It is remarkable that error-free classification of the test set data
was obtained by a number of teams who extracted different
features from the data and used a variety of classification
approaches [1]. For example, Vilar et al. employed a histogram
based classifier in connection with the Kullback-Leibler divergence
used as an entropic distance measure [16]. Amar et al. also
extracted statistical moments from the data, but applied Support
Vector Machine Regression, subsequently [22]. Logistic Re-
gression was applied successfully by Manninen et al. [23]. Strickert
and Seifert based their predictions on a method termed
Correlative Matrix Mapping [24]. Using their software library
Jstacs [25], Keilwagen and Grau built a weighted ensemble of
classifiers which also achieved perfect classification.
An additional ranking of the best performing teams was
suggested by the organizers in retrospect [1,3,26]. It hinges on
interpreting the submitted scores as probabilistic assignments and
on the reliability of the test set labels. In our opinion, the suggested
posterior ranking according to, e.g., the Pearson correlation
between scores s and the test set class labels is questionable, see
also the DREAM6 discussion forum at [3].
Characteristics of the GMLVQ Classifier
Apart from yielding the actual classification scheme, the
GMLVQ analysis provides insights into the structure of the data
which become available by inspection of the prototypes and
relevance matrix. The interpretability of the classifier has proven
useful in several applications and facilitates discussions with the
respective domain experts [27,28].
Figure 5. Test set predictions. GMLVQ based score s vs. patient number m in the test set (left panel) and ordered according to s (right panel). The
dotted line marks an example posterior choice of the threshold H, cf. Eq. (5), for crisp classification yielding correct prediction of 20 AML patients in
the test set.
doi:10.1371/journal.pone.0059401.g005
Figure 6. Visualization of the data set as obtained by GMLVQ.
Projections of normalized feature vectors on the leading eigenvectors
of L are displayed. Green circles correspond to healthy donors, red
symbols mark AML patients in the training set, while blue dots
represent test set data. Stars indicate the positions of the prototypes.
The red arrow marks patient m~116 in the training set, who is labeled
as AML but is misclassified persistently for a large range of thresholdsH,
cf. Eq. (5).
doi:10.1371/journal.pone.0059401.g006
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Figure 7 visualizes the difference vector (w2{w1) of prototypes
representing healthy donors (1) and AML patients (2), respectively.
For the sake of clarity, we have shown only the 31 components
which correspond to the features meanj , cf. Eq. ( a). A positive
difference corresponds to markers which display a greater value in
the AML prototype compared to the typical healthy donor in the
data set, examples being HLA-DR-FITC (j~9), CD117-PE
(j~16), and CD34-PC5 (j~23). Example markers which display
reduced values meanj in AML patients are CD15-FITC (j~7),
CD16-PC5 (j~21), and CD10-PC7 (j~31).
In addition we analysed the resulting relevance matrix





ij which formally accumulate the importance of feature
i for the resulting classification.
The direct interpretation of L is simplified if all features assume
values on the same order of magnitude. This condition was
realized here by the explicit z-score transformation mentioned
above. Moreover, it is important to note that, given a particular set
of feature vectors xm and prototypes wj , a continuum of matrices V
may exist which yield the same distances d(xm,wj), cf. Eq. (3) and,
hence, the same classification scheme with respect to the training
data. This ambiguity problem is particularly pronounced for inter-
dependent or highly correlated features in high dimension.
Resulting difficulties concerning the interpretation of L in terms
of feature relevances are discussed in depth in [28]. There,
schemes are suggested for posterior regularization which provide
unique, interpretable V and L which we also applied here: Note









can be added to the rows of a given Vraw without changing the
GMVLQ cost function (4) and the actual classification of training
data. In [28] a column space projection is suggested in order to





is constructed from the eigenvectors um of C with eigenvalues zero.
Zero eigenvalues of C reflect the presence of linear dependent
or strongly correlated features and the corresponding eigenvectors
mark directions in input space in which training samples and
prototypes do not vary. In the data considered here, one clearly
expects dependencies between related markers, the four versions of
IgG1 being an obvious example. In addition, extracted features
like stdj and iqrj or meanj and medj should be strongly correlated.
For the following discussion we determined V by means of
a posterior column space projection (9) with Y retaining only the
leading eigendirections of C with eigenvalues §10{12. Thereaf-





computed the regularized L~VTV.
It is remarkable that, in the given problem, this posterior
regularization has very little influence on the test set classification.
In particular, the ordering of test set scores obtained with the
regularized system is the same as the one presented in the previous
section. This suggests that the correlations and dependencies
observed in the training set are already representative for the
entire data. In [28] example problems are presented where the
posterior regularization has a non-trivial effect also on test set
performance.
Figure 8 displays the diagonal entries of L for all 186 features.
After regularization, the heuristic interpretation of Lii as the
relevance or significance of feature xj in the classification is
justified [28]. The figure displays the features in groups of six,
corresponding to the 31 markers, cf. Table 1.
A relatively small number of markers appears to contribute the
most significant features: FS-Lin (1), SS-Log (2), CD15-FITC (7),
CD117-PE (16), CD16-PC5 (21), CD34-PC5 (23), and CD10-PC7
(31). A more detailed discussion of the obtained Lii provides
further, valuable information: For instance, the histogram shape as
measured by skewness and kurtosis appears to be of minor
importance with respect to marker 16 (CD117-PE), while
measures of the corresponding histogram width (std, iqr) seem to
Figure 7. GMVLQ prototypes. Components of the difference vector (w2{w1) corresponding to the feature meanj , cf. Eq. (1), as represented by the
AML prototype w2 and healthy donor prototype w
1 . Positive bars indicate that meanj is typically greater in AML patients than in healthy donors.
doi:10.1371/journal.pone.0059401.g007
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1
represent significant differences between AML patients and
healthy donors. On the contrary, for CD10-PC7 (marker 31)
skewness and kurtosis carry most discriminative power.
While several of the above mentioned markers have been
discussed as relevant in the context of AML in the literature, see
e.g. [7,28,29,30], their expression characteristics can vary a lot
with the actual AML variant. For instance, both, HLA-DR
positive and HLA-DR negative types of AML exist [31], the same
applies to several other markers.
Due to the limited size of the data set and because information
about AML subtypes was not disclosed, one should not over-
interpret the results presented above. It is very likely that our
findings in terms of relevances and prototypes are highly specific
for the provided data set which seems to represent particular types
of AML only. Nevertheless, our results demonstrate the in-
terpretability of the GMLVQ approach and illustrate how the
method could be used for efficient biomarker selection in
collaboration with domain experts.
Obviously, the outcome and interpretation of relevance
parameters depends on the precise form of the distance measure,
Eq. (3), or more generally, on the parameterization of the classifier.
For instance, systems with diagonal matrix L could only take into
account single features and would disregard the discriminative
power of particular pairs of features. Accordingly, featurs which
display low relevance in our scheme might become significant in
more complex classifiers. Nevertheless we believe that our method
provides valuable insight into the discriminative power of features
and pairs of features. The following simple experiment further
illustrates this claim: We ranked features according to the
corresponding Lii and restricted the obtained GMLVQ classifier
to the use of only 18 features for classification. All other features
were omitted when evaluating distances and scores, cf. Eqs. (3,5),
no re-training of the system was performed. The restricted
classifier was evaluated in terms of its test set ROC. Close to
perfect test set classification with an AUC&1 was retained when
using only the leading 18 features which all are derived from the
above mentioned 7 markers. It is interesting to note that also the
following two subsets of 18 features, i.e. with relevance ranks 19–
36 and 37–54, yielded excellent test set performance. Figure 9
shows how the resulting AUC decreases for subsequent subsets of
18 features with decreasing relevance. Performance deteriorated
when subsets of features with very low relevance were used,
resulting in essentially random class assignments with AUC&0:5.
A more reliable determination of discriminative markers, and
even more so, the selection of a minimal set of features for correct
classification would require systematic validation studies including
the re-training of the GMLVQ system on the respective feature
sets. Due to the limitations of the data provided in the challenge
we postponed this line of research to forthcoming studies.
Outlook
More challenging data sets will have to be inspected to further
demonstrate the usefulness of the approach in the analysis of flow
cytometry data. This should, of course, include the systematic
comparison with other methods. A comparison of various
classifiers in the context of the FlowCAP2/DREAM6 challenge
can be found in [1].
The identification of leukemia subtypes in a larger study
population requires the introduction of several prototypes
representing the class of AML patients. The extension of GMLVQ
Figure 8. Relevance profile. Diagonal relevances Lii of features i~1,2, . . . ,186: Vertical grid lines separate the groups of 6 quantities
corresponding to each of the 31 markers, cf. Table 1. Marker numbers are given explicitly for 7 highly relevant ones.
doi:10.1371/journal.pone.0059401.g008
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in terms of localized distance measures [9,11] appears also
promising in this context.
The reliable identification of feature relevances for marker
selection should also be based on larger, more representative data
sets. For a successful application of GMLVQ for bio-marker
selection in the context of tumor classification see [27]. The
application of multi-class, potentially localized, GMLVQ will open
new routes to the identification of discriminative markers in the
differential diagnosis of AML subtypes. In forthcoming studies, the
consideration of histogram specific distance measures will also be
studied along the lines of [15].
The analysis presented here was based on the entire cell
population of a given subject. More general problems, including
the above mentioned identification of AML subtypes, might
require an analysis on the level of individual cells. We intend to
consider the development of prototype based automated gating
procedures in forthcoming projects.
Available Software
The specific Matlab code used to generate our contribution to
the DREAM6/FlowCAP2 Molecular Classification of Acute Myeloid
Leukemia Challenge 2011 is publicly available at http://www.the-
dream-project.org/story/code [3].
A Matlab toolbox Relevance and Matrix adaptation in Learning Vector
Quantization, including GMLVQ and important variants, is made
available at http://matlabserver.cs.rug.nl/gmlvqweb/web/[32].
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